Source: Oregon Health & Science University
Date: November 16, 2006
Summary:
Neurosurgeons and physicians at Doernbecher Children's Hospital, Oregon Health & Science University, yesterday, Nov. 14, performed the first transplant of purified human fetal neural stem cells into the brain of a study participant with neuronal ceroid lipofuscinosis (NCL), also known as Batten disease. NCL is a rare and fatal neurodegenerative disorder that affects infants and children. The transplant is part of a Phase 1 clinical trial to evaluate the safety and preliminary efficacy of a human central nervous stem cell product developed by StemCells, Inc., Palo Alto, Calif. This one-year trial will involve up to six children with NCL.
No comments:
Post a Comment